Michael Mark
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Blood properties and coagulation
- Prostate Cancer Treatment and Research
Papers in ⓘ
- Oncology 38
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 8
- Bone health and treatments 8
-
- Lung Cancer Treatments and Mutations 17
- Blood properties and coagulation 8
- Occupational and environmental lung diseases 5
- Co-authors
- Walter H. Reinhart (9 shared papers)Roland B. Walter (7 shared papers)Martin Früh (14 shared papers)Sacha I. Rothschild (15 shared papers)Patrizia Froesch (14 shared papers)Dirk Klingbiel (4 shared papers)Roger von Moos (20 shared papers)Sabine Schmid (10 shared papers)
- Journals
- Annals of Oncology (14 papers)Journal of Clinical Oncology (7 papers)Lung Cancer (4 papers)Swiss Medical Weekly (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- SwitzerlandItalyUnited Kingdom
In The Last Decade
Michael Mark
54 papers receiving 494 citations
Peers
Comparison fields: 5 of 71
- Oncology 226
- Pulmonary and Respiratory Medicine 263
- Critical Care and Intensive Care Medicine 28
- Cancer Research 67
- Biochemistry 16
Countries citing papers authored by Michael Mark
This map shows the geographic impact of Michael Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mark more than expected).
Fields of papers citing papers by Michael Mark
This network shows the impact of papers produced by Michael Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mark. The network helps show where Michael Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 55 | |
| 2 | 2005 | 40 | |
| 3 | 2013 | 34 | |
| 4 | 2017 | 29 | |
| 5 | 2001 | 27 | |
| 6 | 2019 | 27 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 24 | |
| 9 | 2020 | 22 | |
| 10 | 2021 | 14 | |
| 11 | 1999 | 13 | |
| 12 | 2022 | 13 | |
| 13 | 2016 | 13 | |
| 14 | 2000 | 12 | |
| 15 | 2019 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 11 | |
| 18 | 2023 | 9 | |
| 19 | 2000 | 8 | |
| 20 | 2015 | 8 |
About Michael Mark
Michael Mark is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Biotechnology, Critical Care and Intensive Care Medicine and Biochemistry, having authored 57 papers that have together received 505 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Bone health and treatments (8 papers), Blood properties and coagulation (8 papers), Erythrocyte Function and Pathophysiology (6 papers) and Occupational and environmental lung diseases (5 papers). The work is most often cited by research in Oncology (226 citations), Pulmonary and Respiratory Medicine (263 citations), Critical Care and Intensive Care Medicine (28 citations), Cancer Research (67 citations) and Biochemistry (16 citations). Michael Mark has collaborated with scholars based in Switzerland, Italy and United Kingdom. Frequent co-authors include Walter H. Reinhart, Roland B. Walter, Martin Früh, Sacha I. Rothschild, Patrizia Froesch, Dirk Klingbiel, Roger von Moos, Sabine Schmid, Thomas A. Neff and Reto Stocker. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Lung Cancer, Swiss Medical Weekly and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.